Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
31
Number of overlapping holdings
16.1%
% of IBB's 212 holdings also in HELX
55.4%
% of HELX's 62 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 8.0% | 5.6% | 5.6% |
|
REGENERON PHARMACEUTICALS | 5.3% | 5.3% | 5.3% |
|
NATERA INC | 2.0% | 3.1% | 2.0% |
|
UNITED THERAPEUTICS CORP | 1.6% | 1.6% | 1.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to HELX
|
GILEAD SCIENCES INC | 9.9% |
|
AMGEN INC | 6.9% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
IQVIA HOLDINGS INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
|
BIOGEN IDEC INC | 2.2% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% |
IBB Underweight Relative to HELX
|
MEDPACE HOLDINGS, INC. | -5.5% |
|
DANAHER CORP | -5.2% |
|
THERMO FISHER SCIENTIFIC INC | -4.9% |
|
KRYSTAL BIOTECH, INC. | -4.6% |
|
ELI LILLY & CO | -4.2% |
 |
SAMSUNG BIOLOGICS CO., LTD. | -3.3% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.6% |
|
IONIS PHARMACEUTICALS, INC. | -2.2% |
 |
SARTORIUS AG PREF | -2.1% |
|
CORTEVA INC | -2.1% |